A Dose-escalation Clinical Study of Intraoperative Photodynamic Therapy of Glioblastoma
Phase 1
Recruiting
- Conditions
- Primary Glioblastoma
- Interventions
- Combination Product: 5-ALA HCl intraoperative Photodynamic Therapy (PDT) at 200 J/cm^2Combination Product: 5-ALA HCl intraoperative Photodynamic Therapy (PDT) at 400 J/cm^2
- First Posted Date
- 2023-02-21
- Last Posted Date
- 2024-12-19
- Lead Sponsor
- Hemerion Therapeutics
- Target Recruit Count
- 12
- Registration Number
- NCT05736406
- Locations
- 🇺🇸
UPMC Hillman Cancer center, Pittsburgh, Pennsylvania, United States
© Copyright 2025. All Rights Reserved by MedPath